Diabetic Med:在初级保健中未经校正就使用HbA 1c是合理的?

2018-12-28 MedSci MedSci原创

近日,国际杂志 《Diabetic Med》上在线发表一项来自哥本哈根初级保健实验室(CopLab)数据库的分析的研究--关于解释HbA 1c在初级保健中的作用以及对贫血和慢性肾病的潜在影响。在初级保健的大量人群中,研究空腹血糖和HbA1c测量之间的关系,以及贫血或慢性肾病对HbA 1c值的解释的临床意义。 从初级保健资源,研究人员检查了HbA1c和空腹血浆葡萄糖以及血红蛋白和估计GFR。

近日,国际杂志 《Diabetic Med》上在线发表一项来自哥本哈根初级保健实验室(CopLab)数据库的分析的研究--关于解释HbA 1c在初级保健中的作用以及对贫血和慢性肾病的潜在影响。在初级保健的大量人群中,研究空腹血糖和HbA1c测量之间的关系,以及贫血或慢性肾病对HbA 1c值的解释的临床意义。

从初级保健资源,研究人员检查了HbA1c和空腹血浆葡萄糖以及血红蛋白和估计GFR。根据慢性肾病阶段和贫血水平对观察结果进行分层。分别评估来自单独的HbA 1c和来自HbA 1c,血红蛋白和估计的GFR 的平均空腹血糖水平。

研究结果显示,在198 346个人中,空腹血浆葡萄糖HbA 1c关系模拟了A1c-衍生平均葡萄糖(ADAG)研究中描述的回归,该研究基于平均毛细血管和间质葡萄糖。空腹血浆葡萄糖-HbA 1c关系在轻度至中度慢性肾病和轻度至中度贫血中未受影响。仅在严重高血糖和并发严重贫血或当估计GFR<45 ml/min /1.73m2时,相关性发生变化,因此贫血中HbA1c低估了葡萄糖浓度,慢性肾病则高估了葡萄糖浓度。估计GFR <30 ml / min /1.73m²的患病率为0.82%,而血红蛋白<81g/l5.0 mmol / l)的患病率为0.11%。

空腹血浆葡萄糖和HbA 1c之间的关系模拟了ADAG研究中包括的糖尿病患者。轻度至中度贫血和CKDHbA 1c作为逆行性血糖的标志物的解释没有显著影响。因此,在初级保健中未经校正就使用HbA 1c似乎是合理的。

原始出处:

R. BorgF. PerssonV. Siersmaet al. Interpretation of HbA1c in primary care and potential influence of anaemia and chronic kidney disease: an analysis from the Copenhagen Primary Care Laboratory (CopLab) Database

本文系梅斯医学(MedSci)原创编译整理,转载需授权!


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1970690, encodeId=b65219e069044, content=<a href='/topic/show?id=fa5d5919df' target=_blank style='color:#2F92EE;'>#Diabetic#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5919, encryptionId=fa5d5919df, topicName=Diabetic)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Fri May 17 10:57:00 CST 2019, time=2019-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1760973, encodeId=64521e6097332, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Tue Jan 01 12:57:00 CST 2019, time=2019-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2015943, encodeId=c65e20159435e, content=<a href='/topic/show?id=33108494c1' target=_blank style='color:#2F92EE;'>#HbA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8494, encryptionId=33108494c1, topicName=HbA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Sun Apr 28 02:57:00 CST 2019, time=2019-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1683127, encodeId=7e65168312e4d, content=<a href='/topic/show?id=9e103223059' target=_blank style='color:#2F92EE;'>#初级保健#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32230, encryptionId=9e103223059, topicName=初级保健)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bf327942704, createdName=xre2017, createdTime=Mon Jan 07 10:57:00 CST 2019, time=2019-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638942, encodeId=4237163894205, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Apr 29 03:57:00 CST 2019, time=2019-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609424, encodeId=a375160942414, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Dec 30 00:57:00 CST 2018, time=2018-12-30, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1970690, encodeId=b65219e069044, content=<a href='/topic/show?id=fa5d5919df' target=_blank style='color:#2F92EE;'>#Diabetic#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5919, encryptionId=fa5d5919df, topicName=Diabetic)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Fri May 17 10:57:00 CST 2019, time=2019-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1760973, encodeId=64521e6097332, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Tue Jan 01 12:57:00 CST 2019, time=2019-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2015943, encodeId=c65e20159435e, content=<a href='/topic/show?id=33108494c1' target=_blank style='color:#2F92EE;'>#HbA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8494, encryptionId=33108494c1, topicName=HbA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Sun Apr 28 02:57:00 CST 2019, time=2019-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1683127, encodeId=7e65168312e4d, content=<a href='/topic/show?id=9e103223059' target=_blank style='color:#2F92EE;'>#初级保健#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32230, encryptionId=9e103223059, topicName=初级保健)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bf327942704, createdName=xre2017, createdTime=Mon Jan 07 10:57:00 CST 2019, time=2019-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638942, encodeId=4237163894205, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Apr 29 03:57:00 CST 2019, time=2019-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609424, encodeId=a375160942414, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Dec 30 00:57:00 CST 2018, time=2018-12-30, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1970690, encodeId=b65219e069044, content=<a href='/topic/show?id=fa5d5919df' target=_blank style='color:#2F92EE;'>#Diabetic#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5919, encryptionId=fa5d5919df, topicName=Diabetic)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Fri May 17 10:57:00 CST 2019, time=2019-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1760973, encodeId=64521e6097332, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Tue Jan 01 12:57:00 CST 2019, time=2019-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2015943, encodeId=c65e20159435e, content=<a href='/topic/show?id=33108494c1' target=_blank style='color:#2F92EE;'>#HbA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8494, encryptionId=33108494c1, topicName=HbA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Sun Apr 28 02:57:00 CST 2019, time=2019-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1683127, encodeId=7e65168312e4d, content=<a href='/topic/show?id=9e103223059' target=_blank style='color:#2F92EE;'>#初级保健#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32230, encryptionId=9e103223059, topicName=初级保健)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bf327942704, createdName=xre2017, createdTime=Mon Jan 07 10:57:00 CST 2019, time=2019-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638942, encodeId=4237163894205, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Apr 29 03:57:00 CST 2019, time=2019-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609424, encodeId=a375160942414, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Dec 30 00:57:00 CST 2018, time=2018-12-30, status=1, ipAttribution=)]
    2019-04-28 智智灵药
  4. [GetPortalCommentsPageByObjectIdResponse(id=1970690, encodeId=b65219e069044, content=<a href='/topic/show?id=fa5d5919df' target=_blank style='color:#2F92EE;'>#Diabetic#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5919, encryptionId=fa5d5919df, topicName=Diabetic)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Fri May 17 10:57:00 CST 2019, time=2019-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1760973, encodeId=64521e6097332, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Tue Jan 01 12:57:00 CST 2019, time=2019-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2015943, encodeId=c65e20159435e, content=<a href='/topic/show?id=33108494c1' target=_blank style='color:#2F92EE;'>#HbA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8494, encryptionId=33108494c1, topicName=HbA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Sun Apr 28 02:57:00 CST 2019, time=2019-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1683127, encodeId=7e65168312e4d, content=<a href='/topic/show?id=9e103223059' target=_blank style='color:#2F92EE;'>#初级保健#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32230, encryptionId=9e103223059, topicName=初级保健)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bf327942704, createdName=xre2017, createdTime=Mon Jan 07 10:57:00 CST 2019, time=2019-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638942, encodeId=4237163894205, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Apr 29 03:57:00 CST 2019, time=2019-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609424, encodeId=a375160942414, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Dec 30 00:57:00 CST 2018, time=2018-12-30, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1970690, encodeId=b65219e069044, content=<a href='/topic/show?id=fa5d5919df' target=_blank style='color:#2F92EE;'>#Diabetic#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5919, encryptionId=fa5d5919df, topicName=Diabetic)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Fri May 17 10:57:00 CST 2019, time=2019-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1760973, encodeId=64521e6097332, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Tue Jan 01 12:57:00 CST 2019, time=2019-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2015943, encodeId=c65e20159435e, content=<a href='/topic/show?id=33108494c1' target=_blank style='color:#2F92EE;'>#HbA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8494, encryptionId=33108494c1, topicName=HbA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Sun Apr 28 02:57:00 CST 2019, time=2019-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1683127, encodeId=7e65168312e4d, content=<a href='/topic/show?id=9e103223059' target=_blank style='color:#2F92EE;'>#初级保健#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32230, encryptionId=9e103223059, topicName=初级保健)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bf327942704, createdName=xre2017, createdTime=Mon Jan 07 10:57:00 CST 2019, time=2019-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638942, encodeId=4237163894205, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Apr 29 03:57:00 CST 2019, time=2019-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609424, encodeId=a375160942414, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Dec 30 00:57:00 CST 2018, time=2018-12-30, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1970690, encodeId=b65219e069044, content=<a href='/topic/show?id=fa5d5919df' target=_blank style='color:#2F92EE;'>#Diabetic#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5919, encryptionId=fa5d5919df, topicName=Diabetic)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8949377, createdName=chenzhuanggui, createdTime=Fri May 17 10:57:00 CST 2019, time=2019-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1760973, encodeId=64521e6097332, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Tue Jan 01 12:57:00 CST 2019, time=2019-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2015943, encodeId=c65e20159435e, content=<a href='/topic/show?id=33108494c1' target=_blank style='color:#2F92EE;'>#HbA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8494, encryptionId=33108494c1, topicName=HbA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Sun Apr 28 02:57:00 CST 2019, time=2019-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1683127, encodeId=7e65168312e4d, content=<a href='/topic/show?id=9e103223059' target=_blank style='color:#2F92EE;'>#初级保健#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32230, encryptionId=9e103223059, topicName=初级保健)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bf327942704, createdName=xre2017, createdTime=Mon Jan 07 10:57:00 CST 2019, time=2019-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638942, encodeId=4237163894205, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Apr 29 03:57:00 CST 2019, time=2019-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609424, encodeId=a375160942414, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Dec 30 00:57:00 CST 2018, time=2018-12-30, status=1, ipAttribution=)]

相关资讯

可导致心力衰竭的因素有哪些?

随着人们生活水平和医疗技术的不断进步和发展,人们的人均寿命不断延长,老龄人口增多,心力衰竭的发病人数不断增加,那么哪些因素会引起心力衰竭呢?

这些糖尿病患者需要筛查甲状腺功能,高达24%的患病率!

张女士今年31岁,在她25岁时,她感觉精力越来越差,而以往的她总是精力旺盛,晚上下班回家还要约朋友去练一小时瑜伽,而后来她一下班到家就想在沙发上躺着,没有兴致也没有精力去约朋友玩,到了周末,即便晚上睡了十个小时,白天还是瞌睡连连。不仅仅是精疲力竭,工作、社交也受到了影响,而且,她感觉自己的大脑也“力不从心”,用她自己的话来说,很多时候心里明白想说什么,但就是表达不出来,感觉大脑不是自己的。更令张女

周智广:B淋巴细胞亚类与自身免疫糖尿病的胰岛功能

自身免疫糖尿病是由遗传和环境因素共同影响下的器官特异性自身免疫疾病,主要由T细胞介导胰岛β细胞破坏造成胰岛素缺乏所致。但持续增多的证据表明B 淋巴细胞在自身免疫糖尿病发生发展中发挥重要作用。

Diabetic Med:利用体型指数和身体圆度指数鉴别我国东北地区汉族人群糖尿病的能力如何?

近日,国际杂志 《Diabetic Med》上在线发表一项关于利用体型指数和身体圆度指数鉴别我国东北地区汉族人群糖尿病的能力如何的横断面研究。 研究除了评估利用体型指数和身体圆度指数鉴别我国东北地区汉族人群糖尿病的能力,并确定体型指数和身体圆度指数是否优于传统的身体质量指数-BMI。 研究人员于2012年在吉林省,采用多阶段分层随机整群抽样方法共招募15 078名参与者。收集人口统计

Diabetic Med:冠状动脉计算机断层扫描血管造影评估新诊断的2型糖尿病冠状动脉斑块成分的性别差异与低度炎症的关联

近日,国际杂志 《Diabetic Med》上在线发表一项关于冠状动脉计算机断层扫描血管造影评估新诊断的2型糖尿病冠状动脉斑块成分的性别差异与低度炎症的关联的研究。本研究目的探讨新诊断的2型糖尿病患者与未发现心血管疾病的患者在冠状动脉斑块组成和炎症生物标志物方面的差异 共有88名新诊断(<1年)2型糖尿病患者接受了对比增强冠状动脉计算机断层扫描血管造影。使用半自动化软件进行高级冠状动

Diabetic Med:WHO-5和BDI-II是糖尿病患者抑郁症的可接受的筛查工具

近日,国际杂志 《Diabetic Med》上在线发表一项关于WHO-5和BDI-II是糖尿病患者抑郁症的可接受筛查工具的研究。 通过比较三个筛查组(1)WHO -5,(2)BDI-II和(3)WHO-5和BDI-II,调查两份问卷的可接受性,即五项WHO健康指数(WHO-5)和Beck抑郁量表II(BDI-II),它们在长度和重点上有所不同。 共有699名糖尿病患者参与了该研究,